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Biofuels are the most immediate, practical solution for mitigating
dependence on fossil hydrocarbons, but current biofuels (alcohols
and biodiesels) require signiﬁcant downstream processing and are
not fully compatible with modern, mass-market internal combus-
tion engines. Rather, the ideal biofuels are structurally and chem-
ically identical to the fossil fuels they seek to replace (i.e., aliphatic
n- and iso-alkanes and -alkenes of various chain lengths). Here we
report on production of such petroleum-replica hydrocarbons in
Escherichia coli. The activity of the fatty acid (FA) reductase com-
plex from Photorhabdus luminescens was coupled with aldehyde
decarbonylase from Nostoc punctiforme to use free FAs as sub-
strates for alkane biosynthesis. This combination of genes enabled
rational alterations to hydrocarbon chain length (Cn) and the pro-
duction of branched alkanes through upstream genetic and exog-
enous manipulations of the FA pool. Genetic components for
targeted manipulation of the FA pool included expression of a thi-
oesterase from Cinnamomum camphora (camphor) to alter alkane
Cn and expression of the branched-chain α-keto acid dehydroge-
nase complex and β-keto acyl-acyl carrier protein synthase III from
Bacillus subtilis to synthesize branched (iso-) alkanes. Rather than
simply reconstituting existing metabolic routes to alkane produc-
tion found in nature, these results demonstrate the ability to design
and implement artiﬁcial molecular pathways for the production of
renewable, industrially relevant fuel molecules.
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The demand for transport fuel currently represents 60% ofglobal oil production (1) and is predicted to rise from 85million
barrels a day in 2007 to 104million barrels a day by 2030 because of
a combination of population growth, industrialization, and in-
creasing prosperity (2). Moreover, the bulk of crude oil production
is increasingly located in regions of global insecurity, leading to
episodic disruptions in market supply and increased fuel costs.
Finally, the transport sector is the second biggest source of global
greenhouse gas emissions (1) and a politically acceptable target for
CO2 emission mandates: within the European Union, retail fuels
are mandated to contain at least 5% renewable biofuel, rising to
10% by 2020 (3), with similar blending mandates enacted in the
United States, China, and Brazil. Currently, retail biofuels fall into
two categories: alcohols and biodiesel. Alcohols (predominantly
ethanol) are blended with gasoline (petrol), and biodiesels (fatty
acid (FA) alkyl esters and hydrogenated vegetable oils) are blended
with automotive gas-oil (diesel). These biofuels, however, entail
substantial downstream processing and quality control costs and
are not fully compatible with modern, mass-market, high-perfor-
mance, low-emission engines (4–6). Simply increasing the pro-
portion of current biofuel to petroleum distillate in retail fuels
presents signiﬁcant challenges for the entire transport sector.
Without costly and time-consuming infrastructure and engine
remodeling, the maximum blend ratio of biofuel to petroleum-
distillate (the blend wall) is between 10% and 20% (4). Conse-
quently, without a dramatic change in vehicle technology and fuel
supply infrastructure, 80–90% of transport fuel demand cannot be
met through replacing petroleum-derived fuels with the biofuels
currently available.
To overcome the end-user blend wall, it is essential to generate
precise chemical replacements to fossil fuels through sustainable
means. Retail transport fuels are composed primarily of hydro-
carbons (n-alkanes) of various carbon chain lengths (Cn), branched
hydrocarbons (iso-alkanes), and unsaturated hydrocarbons (n-
alkenes). The ideal biofuels are therefore n-alkanes, iso-alkanes,
and n-alkenes that are chemically and structurally identical to the
fossil fuels they are designed to replace.
Biogenic alkanes are found throughout nature (7–12), but
not in the required form for direct replacement fuels; new
pathways for the biological production of different alkanes
must therefore be developed. The only genetically character-
ized alkane biosynthesis pathways are the production of very
long chain alkanes (>C28) by Arabidopsis thaliana (7) and the
production of pentadecane (C15:0) and heptadecane (C17:0) by
cyanobacteria (8). The cyanobacterial alkane pathway has also
been biochemically characterized: fatty acyl-acyl carrier pro-
tein (ACP) is reduced to fatty aldehyde (Cn) by acyl-ACP
reductase (AR), which is then decarbonylated to an alkane
(Cn-1) by fatty aldehyde decarbonylase (AD), primarily pro-
ducing heptadecene (C17:1) in Escherichia coli and releasing
formate (8, 13, 14). To advance biologically synthesized alkanes
further into the fuel market, they must meet the technical re-
quirements demanded of retail fuels, not the requirements of the
source organism.
The objective of the present study was to address the problem
of direct fossil fuel replacements through the de novo design and
assembly of synthetic metabolic pathways, with the aim of pro-
ducing linear and branched-chain alkanes and alkenes of variable,
but speciﬁed, Cn. To achieve this aim, we engineered E. coli cells
to use free FAs directly, rather than the FA thioesters used by the
native cyanobacterial pathway (8). Exploiting free FAs as entry
substrates for alkane synthesis meant that predictable alterations
to the hydrocarbon output of the cells was possible by mod-
iﬁcations to the free FA pool, either by additional pathway en-
gineering or by exogenous supplementation of the media. Using
this strategy, E. coli expressing different molecular modules
produced linear tridecane (C13:0), tridecene (C13:1), pentadecane,
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pentadecene (C15:1), hexadecane (C16:0), hexadecene (C16:1),
heptadecane, heptadecene, and branched tridecane and penta-
decane, thereby replicating the chemical and structural
requirements of retail diesel hydrocarbons commonly used in
temperate climates. The results thus provide proof of principle for
the metabolic production of industrially relevant direct petroleum-
replica hydrocarbons.
Results and Discussion
Design and Assembly of an Artiﬁcial Alkane Biosynthetic Pathway in
E. coli. Alkane production in E. coli through the cyanobacterial
biosynthetic pathway produces linear C15:0 and C17:1 aliphatic
hydrocarbons from the intermediate of fatty acid biosynthesis,
fatty acyl-ACP (8). We considered that conversion of free FAs,
rather than fatty acyl-ACP, to alkanes was a more tractable target
for bio-alkane production (Fig. 1A) for three main reasons: First,
exploiting the FA pool would provide a mechanism to direct al-
kane biosynthesis to different Cn alkanes because heterologous
expression of thioesterases in E. coli introduces control over FA
Cn (15, 16); second, FAs are more abundant in cells than fatty
acyl-ACP; and third, the FA pool can be substantially increased
through genetic manipulation (17–19). Our ﬁrst aim was there-
fore to exploit FAs as substrates for alkane biosynthesis. To
achieve this, we generated and expressed in E. coli an artiﬁcial
metabolic pathway in which the FA reductase (FAR) complex
(20, 21), encoded by the genes luxC, luxE, and luxD from the
bioluminescent bacterium Photorhabdus luminescens, supplied
the appropriate Cn fatty aldehyde substrate to an aldehyde
decarbonylase (NpAD) cloned from Nostoc punctiforme (Fig. 1B,
red). Coexpression of luxC, luxE, luxD, and the aldehyde decar-
bonylase gene (collectively termed CEDDEC) in E. coli cells
resulted in the production of alkanes and alkenes of the appro-
priate chain length for diesel or aviation fuel, namely tridecane,
pentadecane, pentadecene, hexadecene, heptadecane, and hepta-
decene (Fig. 1C). By comparison, expression of AR and AD from
N. punctiforme in E. coli led to the production of heptadecane,
heptadecene, and pentadecane (Fig. 1C) as described previously
(8). Together, these data demonstrate that the P. luminescens FAR
complex provided suitable substrates for n-alkane and n-alkene
biosynthesis in the engineered E. coli, as predicted.
Modiﬁcation to the FA Pool Results in Predictable Changes to the
Output of the Artiﬁcial Alkane Biosynthesis Pathway. The ratio-
nale for the development of free FAs as a pool for alkane bio-
synthesis was that it would provide a substrate that was more
tractable for ﬁne-tuning the properties of the biofuel molecules.
Such an approach has been successfully used to structurally tailor
the FA ethyl ester and fatty alcohol output of engineered cells
(19). To test whether the synthetic pathway CEDDEC (Fig. 1,
red) was compatible with a modiﬁed FA pool and whether
changes in the FA pool would translate to changes in alkane
output, we predicted that the inclusion of different FAs in the
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Fig. 1. Production of fuel-grade alkanes from FAs by engineered E. coli. (A)
Overview: three independent modiﬁcations to the FA pool (two genetic and
one by exogenous supplementation) resulted in predictable changes to the
output of cells engineered to produce alkane fuels via the artiﬁcial pathway.
(B) Details of the genetic modiﬁcations implemented: the synthetic alkane
biosynthetic pathway (red) was engineered through the coexpression of the
reductase (luxC), synthetase (luxE), and transferase (luxD) genes coding for
the FAR complex from the P. luminescens luciferase operon and the gene
encoding NpAD. For construct details, see Fig. S1. Branched-chain FAs
(green) were produced by expression of genes coding for the BCKD complex
(bkdAA, bkdAB, bkdB, and acoL, which code for E1α, E1β, E2, and E3 sub-
units, respectively) and fabHB encoding KASIII. Isoleucine, leucine, and valine
(ILV) can be converted to α-keto acids through endogenous branched-chain
amino acid aminotransferase activity (encoded by ilvE). MDHLA represents
either S-(3-methylbutanoyl)-dihydrolipoamide E, S-(2-methylpropanoyl)-
dihdrolipoamide E, or S-(2-methylbutanoyl)-dihydrolipoamide E, the prod-
ucts of isoleucine, leucine, or valine breakdown, respectively (Fig. S2). The
E1α, E1β, and E2 subunits convert keto acids to keto acyl-CoA, whereas the
E3 subunit recycles the lipoamide-E cofactor. All branched-chain components
were from B. subtilis. FA chain length was altered through expression of the
FatB1 thioesterase from C. camphora (blue). (C) Hydrocarbons produced by
cells expressing the synthetic alkane pathway (CEDDEC) or the cyanobacte-
rial alkane pathway (AR and AD from N. punctiforme) without modiﬁcations
to the fatty acid pool. n = 6 biological replicates; error bars represent SE of
mean. Cells were grown and induced as detailed in Experimental Procedures.
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growth media (Fig. 1, orange) would result in the production of
different alkanes by the engineered cells; like many microbes, E.
coli possesses the capacity to assimilate exogenous FAs (22). We
compared the alkane products of cells engineered to express the
CEDDEC synthetic pathway with those engineered to express
the cyanobacterial AR/AD pathway when supplied with FAs not
normally present within E. coli. When the growth medium was
supplemented with 13-methyl tetradecanoic acid (a branched
FA), cells expressing the CEDDEC pathway produced branched
tridecane (Fig. 2A). Furthermore, cells expressing CEDDEC
genes produced branched pentadecane and linear hexadecane
when grown in the presence of two other FAs not present within
E. coli: 15-methyl hexadecanoic acid (branched C16:0) and
heptadecanoic acid (C17:0), respectively. The synthetic pathway
was therefore able to use a modiﬁed free FA pool to generate
speciﬁc alkane products whose nature was determined by the
supplied FA. By contrast, cells expressing the N. punctiforme AR/
AD pathway were unable to use exogenous 15-methyl hex-
adecanoic acid (Fig. 2B). To conﬁrm that this was due to an in-
ability of NpAR to use exogenous FA rather than an inability to
use branched substrates, ORF slr1609 from Synechocystis sp. PCC
6803 was also expressed in the cells. ORF slr1609 codes for an
acyl-ACP synthetase whose proposed role is the reactivation of
FAs to fatty acyl-ACP (23). When ORF slr1609 and the N.
punctiforme AR/AD pathway were coexpressed, cells produced
branched pentadecane from exogenous branched FA. Branched
substrates can therefore be used by NpAR. These results are con-
sistent with the hypothesis that fatty acyl-ACP is the sole substrate
for the cyanobacterial pathway in vivo. The results also indicate
that E. coli lacks a mechanism for activating FA to fatty acyl-ACP.
Importantly for this investigation, the results clearly demonstrate
that the alkane biosynthetic CEDDEC pathway is capable of using
branched FA substrates to generate iso-alkanes. The FA pool of
E. coli cells is therefore a suitable substrate provider for the arti-
ﬁcial CEDDECmodule and is a viable target for modifying alkane
output toward industrially relevant molecules.
LuxD Is Required for Alkane Production, but Is Likely to Be Involved in
Protein–Protein Interactions Rather than as a Catalyst. After dem-
onstrating that E. coli cells expressing the CEDDEC pathway are
capable of synthesizing alkanes from an exogenously manipulated
FA pool, we aimed to express additional genetic modules to
manipulate the FA pool in vivo, thereby tailoring the alkane
output of the cells toward the production of compounds used in
retail fuel blends. However, given that our target substrate for
alkane biosynthesis was the free FA pool, it was possible that the
expression of luxD was unnecessary. The luxD gene codes for the
fatty acyl transferase subunit that may provide FA substrate for
fatty acyl synthetase (LuxE) through cleavage of activated FAs
(i.e., fatty acyl-ACP and fatty acyl CoA). The fatty acyl reductase
subunit (LuxC) then uses the acyl-protein thioester product of the
LuxE catalyzed reaction to produce fatty aldehyde (24). Within
the FAR protein complex (a central reductase tetramer with each
subunit interacting with a synthetase subunit), fatty acyl groups
are directly passed between LuxE and LuxC (25). LuxD subunits
interact only weakly with each synthetase subunit (24). If FAs
enter the FAR complex directly through LuxE rather than being
supplied by LuxD, then it may be possible to minimize the
number of heterologously expressed genes (and hence decrease
the cost of protein synthesis to the cells) by omitting luxD from
the luxCED operon.
To explore this possibility, we undertook two experiments.
First, we conﬁrmed that FAs enter alkane biosynthesis through
LuxE. To do this, we expressed CEDDEC in a BL21* (DE3)
expression strain lacking the fadD gene: fadD codes for acyl-CoA
synthetase and strains mutated in fadD cannot produce acyl-
CoAs and cannot grow on exogenous FA (22). In ΔfadD cells,
exogenous FAs will not be converted into their CoA thioesters.
Moreover, E. coli does not appear to possess any capacity to
convert exogenous FA to fatty acyl-ACP (Fig. 2B). If FAs enter
the FAR complex through LuxE rather than LuxD, then exogenous
FA will be converted to alkanes in a ΔfadD strain. Alternatively,
if exogenous FAs need to be activated for use by LuxD, then
exogenous FAs should not be converted to alkanes in a ΔfadD
strain. When CEDDEC was expressed in ΔfadD E. coli supple-
mented with exogenous branched FA, branched alkanes were
produced (Fig. 3A). We therefore concluded that FA directly
enters the alkane biosynthetic pathway through LuxE.
Consequently, it may be possible to reduce the number of
heterologously expressed genes in the CEDDEC module to only
LuxC, LuxE, and NpAD. We therefore removed the luxD gene
from the synthetic operon by digestion with HindIII and NotI
(Fig. S1). Expression of the resulting module (luxC, luxE, and
NpAD without luxD; termed CE-DEC) in E. coli resulted in an
almost complete absence of alkane product (Fig. 3B). Although
the exact nature of the interactions between LuxD and the central
LuxC/LuxE complex is not fully known, LuxD is clearly a crucial
component of the FAR complex and the alkane biosynthesis
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Fig. 2. Predictable modiﬁcations to the alkane output from engineered E. coli
cells inmedia supplementedwith exogenous fatty acids. (A) Typical GC-MS total
ion chromatograms (TIC) of alkanes extracted from E. coli cells that express the
CEDDEC pathway, grown and induced as described in Experimental Procedures
with 100 μg·mL−1 FA supplementation as indicated. *Branched alkaneproducts.
Branched alkanes were identiﬁed by retention time and comparison with the
mass spectral library. Branched alkanes are more likely to fragment at the po-
sition where the branch is located, giving a smaller molecular ion (e.g.,m/z 197
is indicative of methyl pentadecane) with a larger molecular ion peak than
straight chain alkanes. Total alkanes recovered: CEDDEC, 5.8 mg·L−1 ± 0.3;
13-methyl tetradecanoic acid supplement, 5.9 mg·L−1 ± 0.3; 15-methyl hex-
adecanoic acid supplement, 4.3 mg·L−1 ± 0.3; heptadecanoic acid supplement,
7.4 mg·L−1 ± 0.4. (B) GC-MS TIC of hydrocarbons extracted from E. coli cells
expressing the cyanobacterial NpAR/NpAD pathway alone (Left) or in con-
junction with the cyanobacterial (Synechocystis sp. PCC 6803) slr1609 ORF
(Right). Cells were grown and induced as described in Experimental Procedures
and supplemented with 100 μg·mL−1 15-methyl hexadecanoic acid. Total
alkanes recovered: cyanobacterial pathway alone, 1.5 mg·L−1 ± 0.03; in com-
bination with slr1609, 0.8 mg·L−1 ± 0.02.
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module. Previously, LuxD has been hypothesized to be important
in FAR complex activity through protein-protein interactions
between the carboxyl terminal regions of LuxD and LuxE (26)
(rather than having a direct catalytic activity as a fatty acyl trans-
ferase) and our data support this proposal.
Biosynthesis of Branched Alkanes from in Vivo Biosynthesis of
Branched FAs in E. coli. Having demonstrated that supplementary
FAs can be converted to their corresponding Cn-1 alkanes and
alkenes (Fig. 2), we sought to manipulate the internal FA pools
genetically because supplementation of exogenous FAs is not
a practicable feedstock for biofuel production.
Our ﬁrst aim was to produce branched alkanes biosynthetically.
The presence of branched-chain molecules within fuel blends is
necessary to maintain performance at low temperature and high
altitude. Having previously demonstrated the capacity for in-
corporation of exogenous, branched FAs into the CEDDEC al-
kane biosynthetic pathway (Fig. 2), we designed a branched-chain
FA biosynthetic module (Fig. 1, green) that would generate
branched FA substrates.WTE. coli is unable to produce branched
FAs endogenously because the native β-ketoacyl-ACP synthase III
(KASIII) enzyme that catalyses the initial step in the FA elonga-
tion cycle accepts only linear acetyl-CoA or propionyl-CoA sub-
strates. Moreover, the substrates required by KASIII for branched
FAs are not present within E. coli (27). Many gram-positive
bacteria do, however, produce branched-chain FAs (28), and
branched-chain FAs can be produced in vitro by the FA elongation
enzymes from E. coli if an alternative KASIII enzyme and suitable
precursor molecules are present (27, 29). Both the capacity to
incorporate branched starter molecules into the FA elongation
cycle and the pathways to supply these substrates were therefore
introduced into E. coli by expression of KASIII (FabH2) and the
branched-chain α-keto acid dehydrogenase (BCKD) complex
from Bacillus subtilis (Fig. 1B and Figs. S1 and S2). We reasoned
that the substrates for the BCKD complex would be supplied
through the endogenous activity of branched-chain amino acid
aminotransferase (E.C. 2.6.1.42) in E. coli, using the branched
amino acids isoleucine, leucine, and valine as substrates. In-
troducingB. subtilisKASIII activity intoE. coliwould then provide
branched molecules as starter substrates for the endogenous FA
elongation cycle, and thence for the CEDDEC module.
As expected, coexpression of the FabH2 KASIII and the
BCKD complex from B. subtilis in E. coli resulted in the pro-
duction of the branched-chain FAs 13-methyl tetradecanoic acid
and 15-methyl hexadecanoic acid (Fig. 4A), thereby demon-
strating branched FA biosynthesis in vivo in E. coli. To de-
termine if it were possible to produce branched FAs and to
convert them into branched alkanes in the same cells, both the
branched FA biosynthesis module (Fig. 1, green) and alkane
biosynthesis module CEDDEC (Fig. 1, red) were simultaneously
expressed in E. coli. We observed that expressing all nine genes
from both modules (bkdAA, bkdAB, bkdB, acoL, fabHB, luxC,
luxE, luxD, and NpAD) simultaneously in E. coli had a negative
impact on the level of recombinant protein synthesis compared
with cells engineered with CEDDEC alone. Consequently, the
amount of alkanes produced by these cells was also reduced
compared with the baseline established by those expressing
CEDDEC. Despite this limitation, a range of different alkane and
alkene products was detected including the branched alkane,
methyl pentadecane (Fig. 4B). The results therefore clearly
demonstrate the feasibility of engineering artiﬁcial pathways for
branched alkane biosynthesis in a microbial host.
Genetic Control over Alkane Chain Length. Our second aim was to
tailor the Cn of the alkanes: this ability is critical for industrial
applications because Cn largely deﬁnes the properties of the fuel
(30). FatB1 is a thioesterase from Cinnamomum camphora
(camphor) responsible for terminating FA elongation by cleaving
the growing fatty acyl-ACP chain, releasing FA and an ACP
molecule (15, 16). The FatB1 thioesterase from C. camphora is
speciﬁc for C14 fatty acyl-ACP chains and has been used heter-
ologously to manipulate FA pools: in E. coli, the expression of
fatB1 (without the endogenous transit peptide) results in the
synthesis of tetradecanoic acid (C14:0) (15). We therefore pre-
dicted that the coexpression of fatB1 and CEDDEC in E. coli
would result in a modiﬁed FA pool that, because of the domi-
nance of C14 FAs, would yield predominantly C13 alkanes. The
CEDDEC/FatB1 combination resulted in a large increase in the
tetradecanoic acid pool and the almost exclusive production of
tridecane in the engineered E. coli (Fig. 5 and Figs. S3 and S4).
Conversion of FA to Alkanes Is Limited by the in Vivo Use of Fatty
Aldehyde Substrate. In the system presented here, alkane titers
from both the cyanobacterial pathway and the artiﬁcial CEDDEC
pathway were ∼2–5 mg·L−1 24 h after induction (Fig. 1 and
Fig. S5). These values are in agreement with a recent report for
expression of the cyanobacterial pathway in BL21* (DE3) cells
(31). Such titers were encountered even in the presence of the
high concentrations of FAs achieved through exogenous feeding
(Fig. 2A) or following expression of FatB1 (Fig. 5A). Alkane titers
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Fig. 3. LuxD is an essential component of the artiﬁcial alkane biosynthetic
(CEDDEC) pathway. (A) GC-MS TIC of hydrocarbons extracted from E. coli
cells expressing CEDDEC in ΔfadD BL21* (DE3) in the presence of 100 μg·mL−1
13-methyl tetradecanoic acid. (B) GC-MS TIC of hydrocarbons extracted from
WT E. coli cells expressing CE-DEC (luxC, luxE, and NpAD with the luxD gene
removed from the operon; Fig. S1). The absence of pentadecane is indicated
by the gray arrow. All cells were grown and induced as described in Exper-
imental Procedures.
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Fig. 4. De novo production of branched fatty acids and alkanes in E. coli. (A)
Typical GC-MS TIC of FAs extracted from control cells without BCKD/KASIII
expression (Left) or from cells expressing BCKD/KASIII (Right). *Branched FA
products [methyl tetradecanoic acid (14:0*) and methyl hexadecanoic acid
(16:0*)]. Total FA recovered from control cells, 0.6 mg·L−1 ± 0.2 in control
lines; for cells expressing BCKD/KASIII, 2.5 mg·L−1 ± 0.4. (B) Typical GC-MS TIC
of alkanes extracted from control cells expressing CEDDEC (Left) and cells
coexpressing BCKD/KASIII and CEDDEC (Right). *Branched alkane product
[methyl pentadecane (15:0*) absent in CEDDEC]. Mass spectral data for
methyl pentadecane are given in Fig. S3.
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reported previously for heterologous expression of the cyano-
bacterial pathway however were in the region of 10–80 mg·L−1 48 h
postinduction (7). To determine if the FAR complex was limiting
ﬂux from FA to alkanes, we assayed the intermediate metab-
olite of the alkane biosynthetic pathway, fatty aldehyde. In cells
expressing the CEDDEC pathway, there is a greater pool of fatty
aldehydes than in control cells and in cells expressing the cya-
nobacterial pathway (Fig. 6). Moreover, in the presence of ex-
ogenous tetradecanoic acid, there were further signiﬁcant
increases in the pool of C14 fatty aldehyde (Fig. 6 and Fig. S6).
The fatty aldehyde content however was small compared with
total pool size for alkanes and FAs. Fatty aldehydes may be
converted to fatty alcohols in E. coli cells by endogenous alde-
hyde reductases (32, 33). We therefore also examined the fatty
alcohol content of these cells. As with fatty aldehydes, the fatty
alcohol content was greater in the cells expressing the CEDDEC
pathway than in those expressing the cyanobacterial pathway or
in control cells (Fig. 5B). Moreover, feeding with exogenous FAs
further increased the fatty alcohol content. Although we con-
clude that the FAR complex does not currently limit ﬂux into this
pathway (and creates a larger pool of aldehyde substrate for the
decarbonylase reaction than the cyanobacterial AR), the accu-
mulation of fatty alcohols indicates potential in vivo competition
for aldehyde substrate between the decarbonylase-catalyzed re-
action and aldehyde reductase reactions. Future engineering
strategies will therefore need to focus on improving the ﬂux
through the decarbonylase-catalyzed reaction by increasing the
ability of AD to convert aldehydes to alkanes and removal of
the competing reaction(s).
Conclusions
The objective of this study was to determine if it were possible to
develop a unique biological route for the production of in-
dustrially-relevant alkanes and alkenes. We have engineered in
E. coli pathways for the production of speciﬁed, aliphatic n- and
iso-alkanes and -alkenes of various chain lengths that are exact
replicas of petroleum-based molecules used in retail fuels.
Rather than using fatty acyl-ACPs as substrates, the modules
described here exploit the free FA pool as the primary substrate
for alkane biosynthesis. This approach ensured that the hydro-
carbon output of the engineered cells could be altered by ra-
tional modiﬁcations to the FA pool. This capacity for designer
alkane production was demonstrated by expression of a thio-
esterase from C. camphora to alter alkane Cn, by expression of
the branched-chain α-keto acid dehydrogenase complex and
β-keto acyl-ACP synthase III from B. subtilis to synthesize
branched alkanes, and by inclusion of exogenous FAs in the
growth media in cells expressing a unique alkane biosynthetic
pathway. One of the most important characteristics of the ge-
netic modules described here is that there is no “blend wall” for
the biologically generated fossil-fuel replicas synthesized. The
identiﬁcation of limitations in conversion of aldehydes to alkanes
and of an alternative metabolic sink provides a focus for future
engineering strategies: these may involve removing competing
reactions, generating an intracellular environment in which the
decarbonylase can more efﬁciently use the fatty aldehydes gen-
erated by the ﬁrst step of the pathway or improving the efﬁciency
of the decarbonylase itself. The size of the challenge facing ad-
vanced biofuels can be appreciated when considering the effort
necessary to progress the engineered biosynthesis of semi-
synthetic artemisinin from the laboratory to commercial pro-
duction: many changes beyond manipulating the endogenous
mevalonate pathway have been required, including changes to
host cell biology, fermentation conditions, and extraction pro-
cedures (34, 35). The application of engineering, life-cycle,
and economic costing analysis for scale-up procedures combined
with the exploitation of alternative, nonfood carbon sources to
break the link between food and fuel prices (17–19, 36–39)
and new approaches to engineering metabolism [exempliﬁed by
the development of dynamic sensor-regulator systems for FA-
derived products (40), the remarkable reversal of the β-oxidation
cycle (41), and introduction of molecular scaffolds for improving
metabolic efﬁciency (42, 43)] will facilitate this aim. The results
presented in this article, although at a very early stage in product
development, contribute toward the goals of advanced biofuels
by providing metabolic pathways for the production of in-
dustrially relevant, petroleum-replica fuel molecules.
Experimental Procedures
Construction of Expression Plasmids. Genes from the P. luminescens luxoperon
were reverse-translated and codon-optimized for expression in E. coli using
DNA2.0 GeneGPS Technology, and synthesized as a single operon by DNA2.0
into the pACYCDuet-1 expression vector (Novagen) multiple cloning site
(MCS) 1. The decarbonylase gene was cloned from N. punctiforme genomic
DNA as described in Fig. S1. The thioesterase amino acid sequence Q39473.1
(minus the chloroplast transit peptide) and sequences for BCKD compo-
nents (NP_390285.1, NP_390284.1, NP_390283.1, and ZP_03600867.1) and
for KASIII FabH2 (NP_388898.1) were reverse-translated and codon-opti-
mized for expression in E. coli using DNA2.0 GeneGPS Technology, syn-
thesized by DNA2.0 and cloned into pETDuet-1MCS1 using NcoI and NotI sites.
All cloningwas carriedout using TOP10 chemically competent cells (Invitrogen).
Metabolic Engineering. Unless otherwise speciﬁed, E. coli BL21* (DE3) cells,
transformed with the relevant expression vector, were grown in modiﬁed
minimal medium (MMM) (7) with 3% (wt/vol) glucose, 0.5 g·L−1 yeast ex-
tract, and the relevant antibiotic. The inclusion of a small amount of yeast
extract ensured the rapid and reliable growth required for laboratory
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Fig. 5. Production of tridecane in E. coli. (A) Total FAs extracted from cells
expressing CEDDEC alone or CEDDEC in conjunction with the FatB1 thio-
esterase from C. camphora. n = 3 biological replicates; error bars represent
SE of the mean. Cells were grown and induced as detailed in Experimental
Procedures. Typical GC-MS TIC is given in Fig. S4. (B) Typical GC-MS TIC of
hydrocarbons extracted from cells expressing CEDDEC and FatB1. Putative
identiﬁcation of trans-5-dodecanal or tetradecanal (peak 1) and tridecanone
(peak 2) were identiﬁed in cells expressing FatB1 with and without CEDDEC.
Mass spectral data for tridecane are given in Fig. S3. Total alkanes recovered
from cells expressing CEDDEC/FatB1, 2.9 mg·L−1 ± 0.1.
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Fig. 6. Identiﬁcation of alkane biosynthesis limitations in the E. coli host.
Total alkane, aldehyde (C14 and C16), and fatty alcohols (C14 and C16)
extracted from control cells [BL21* (DE3)], cells expressing the cyanobacterial
pathway (NpAR/NpAD), the artiﬁcial CEDDEC pathway, and the artiﬁcial
CEDDEC pathway supplemented with tetradecanoic acid (+ FA). n = 3
biological replicates; error bars represent SE of the mean. Cells were grown
and induced as detailed in Experimental Procedures.
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procedures that we were unable to achieve using MMM. Cells were in-
cubated at 37 °C and 180 rpm, and protein expression was induced with
20 μM isopropylthiogalactoside (IPTG) at O.D.600 of 0.6–0.8. Cells were grown
for a further for 24 h.
Hydrocarbon Analysis. Hydrocarbons (alkanes and fatty alcohols) were ex-
tracted from 8 mL of the cell suspension using an equal volume of ethyl
acetate for 2.5 h as described previously (7), dried under nitrogen, and dis-
solved in dichloromethane. Separation and identiﬁcation of hydrocarbons
was performed using a ThermoQuest Finnigan Trace GC/MS 2000 equipped
with a ZB1-MS column [30 m × 0.32 mm internal diameter (ID), Phenom-
enex]. After splitless injection, the temperature was maintained at 35 °C for
2 min and increased to 320 °C at a rate of 10 °C·min−1 with a subsequent
incubation at 320 °C for 5 min. The injector temperature was 250 °C and the
ﬂow rate of the helium carrier gas was 1.0 mL·min−1. The scan range of the
mass spectrometer was 30–700 m/z at a scan rate of 1.6 scans·s−1. Peak
identiﬁcation was through comparison with known standards, retention
time and mass spectral comparisons with the National Institute of Standards
and Technology database. Quantiﬁcation of alkanes was based on hepta-
decane standards, quantiﬁcation of alkenes was based on heptadecene
standards, and quantiﬁcation of fatty alcohols was based on tetradecanol
standards. FAs were extracted in dichloromethane (DCM): methanol (2:1)
according to the Folch method (44). Samples dissolved in DCM were deriv-
atized using bis(trimethylsilyl)triﬂuoroacetamide (Supelco Analytical) 70 °C
1 h and analyzed using the same GC-MS procedure as for alkane samples.
Aldehydes were extracted from 50-mL cultures by centrifugation. Pellets
were sonicated for 2 h at 40 °C in 1 mL methanol containing 5 mM
semicarbazide hydrochloride and 5% formic acid. Separation and identiﬁ-
cation of semicarbazide aldehyde derivatives was performed as described
(45), using an Agilent 6410 Series triple quadrupole mass spectrometer
interfaced with an Agilent 1200 Series liquid chromatograph. Two multiple
reaction monitoring transitions were monitored for each of 11 different
aldehydes (chain length from C8 to C18).
Construction of a ΔfadD BL21* (DE3) Strain. Targeted replacement of the
entire fadD gene from E. coli BL21* (DE3) with a kanamycin-selectable
marker was performed using Red/ET recombination (Quick and Easy E. coli
Gene Deletion Kit, Gene Bridges GmbH). Primer sequences for ampliﬁcation
of the deletion cassettes and conﬁrming integration of the selectable
markers were fadDF 5′ TATCATTTGGGGTTGCGATGACGACGAACACGCAT-
TTTAGAGGTGAAGAAAATTAACCCTCACTAAAGGGCG 3′ and fadDR 5′ GCG-
TCAAAAAAAACGCCGGATTAACCGGCGTCTGACGACTGACTTAACGCTAATACG-
ACTCACTATAGGGCTC 3′. The manufacturer’s protocol was adapted by the
addition of an additional PCR ampliﬁcation stepusing nestedprimers to increase
the yield of the transforming cassettes: fadDFnest 5′ TATCATTTGGGGTTGC-
GATGACG 3′ and fadDRnest 5′ GCGTCAAAAAAAACGCCGG 3′. Primers for
conﬁrming integration of the selectable markers were Primer 15′ TATTATGT-
TAACGGCATGTATATC 3′, Primer 3 5′ TTGTTTTCTCTTTAGTGGGCGTCA 3′, and
PCR primer 2 5′ CGAGACTAGTGAGACGTGCTAC 3′.
ACKNOWLEDGMENTS. This work was supported by a grant from Shell Re-
search Ltd. and a Biotechnology and Biological Sciences Research Council
(BBSRC) Industry Interchange Partnership grant (to J.L.). D.A.P. is a visiting
research fellow and R.L. is a visiting professor at the University of Exeter.
1. International Energy Agency (2011) Key World Statistics (Paris, France).
2. International Energy Agency (2008) World Energy Outlook (Paris, France).
3. European Directive (2009) Council Directive (EC) 2009/28/EC of 23 April 2009 on the
promotion of the use of energy from renewable sources and amending and sub-
sequently repealing Directives 2001/77/EC and 2003/30/EC.
4. National Renewable Energy Laboratory (2009) Biodiesel Handling and User Guide
(Oak Ridge, TN: US Department of Commerce), 4th Ed.
5. Yuksel F, Yuksel B (2004) The use of ethanol-gasoline blend as a fuel in an SI engine.
Renew Energy 29:1181–1191.
6. Jeuland N, Montagne X, Gautrot X (2004) Potentiality of ethanol as a fuel for dedi-
cated engine. Oil Gas Sci Technol 59:559–570.
7. Bernard A, et al. (2012) Reconstitution of plant alkane biosynthesis in yeast demon-
strates that Arabidopsis ECERIFERUM1 and ECERIFERUM3 are core components of
a very-long-chain alkane synthesis complex. Plant Cell 24(7):3106–3118.
8. Schirmer A, Rude MA, Li XZ, Popova E, del Cardayre SB (2010) Microbial biosynthesis
of alkanes. Science 329(5991):559–562.
9. Perera MADN, et al. (2010) Biological origins of normal-chain hydrocarbons: A
pathway model based on cuticular wax analyses of maize silks. Plant J 64(4):618–632.
10. Burger BV, Reiter B, Borzyk O, du Plessis MA (2004) Avian exocrine secretions. I.
Chemical characterization of the volatile fraction of the uropygial secretion of the
green woodhoopoe, Phoeniculus purpureus. J Chem Ecol 30(8):1603–1611.
11. Howard RW, et al. (1982) Cuticular hydrocarbons of Reticulitermes virginicus (Banks)
(Isoptera, Rhinotermitidae) and their role as potential species-recognition and caste-
recognition cues. J Chem Ecol 8:1227–1239.
12. Bourre JM, Cassagne C, Larrouquère-Regnier S, Darriet D (1977) Occurrence of alkanes in
brainmyelin. Comparisonbetweennormalandquakingmouse. JNeurochem29(4):645–648.
13. Das D, Eser BE, Han J, Sciore A, Marsh ENG (2011) Oxygen-independent decarbon-
ylation of aldehydes by cyanobacterial aldehyde decarbonylase: A new reaction of di-
iron enzymes. Angew Chem Int Ed 50:7148–7152.
14. Warui DM, et al. (2011) Detection of formate, rather than carbon monoxide, as the
stoichiometric coproduct in conversion of fatty aldehydes to alkanes by a cyano-
bacterial aldehyde decarbonylase. J Am Chem Soc 133(10):3316–3319.
15. Yuan L, Voelker TA, Hawkins DJ (1995) Modiﬁcation of the substrate speciﬁcity of an
acyl-acyl carrier protein thioesterase by protein engineering. Proc Natl Acad Sci USA
92(23):10639–10643.
16. Voelker TA, et al. (1992) Fatty acid biosynthesis redirected to medium chains in
transgenic oilseed plants. Science 257(5066):72–74.
17. Youngquist JT, et al. (2012) Kinetic modeling of free fatty acid production in Es-
cherichia coli based on continuous cultivation of a plasmid free strain. Biotechnol
Bioeng 109(6):1518–1527.
18. Liu T, Vora H, Khosla C (2010) Quantitative analysis and engineering of fatty acid
biosynthesis in E. coli. Metab Eng 12(4):378–386.
19. Steen EJ, et al. (2010) Microbial production of fatty-acid-derived fuels and chemicals
from plant biomass. Nature 463(7280):559–562.
20. Westerlund-Karlsson A, Saviranta P, Karp M (2002) Generation of thermostable mo-
nomeric luciferases from Photorhabdus luminescens. Biochem Biophys Res Commun
296(5):1072–1076.
21. Winson MK, et al. (1998) Engineering the luxCDABE genes from Photorhabdus lu-
minescens to provide a bioluminescent reporter for constitutive and promoter probe
plasmids and mini-Tn5 constructs. FEMS Microbiol Lett 163(2):193–202.
22. Rock CO (2008) Fatty acid and phospholipid metabolism in prokaryotes. Biochemistry of
lipids, lipoproteins andmembranes, eds Vance D, Vance J (New York: Elsevier), pp 59–96.
23. Kaczmarzyk D, FuldaM (2010) Fatty acid activation in cyanobacteria mediated by acyl-acyl
carrier protein synthetase enables fatty acid recycling. Plant Physiol 152(3):1598–1610.
24. Meighen EA (1991) Molecular biology of bacterial bioluminescence. Microbiol Rev
55(1):123–142.
25. Wall L, Rodriguez A, Meighen E (1986) Intersubunit transfer of fatty acyl groups
during fatty acid reduction. J Biol Chem 261(34):15981–15988.
26. Li J, Szittner R, Meighen EA (2000) Hyperactivity and interactions of a chimeric myr-
istoryl-ACP thioesterase from the lux system of luminescent bacteria. Biochim Biophys
Acta 1481(2):237–246.
27. Smirnova N, Reynolds KA (2001) Branched-chain fatty acid biosynthesis in Escherichia
coli. J Ind Microbiol Biotechnol 27(4):246–251.
28. Kaneda T (1991) Iso- and anteiso-fatty acids in bacteria: Biosynthesis, function, and
taxonomic signiﬁcance. Microbiol Rev 55(2):288–302.
29. Choi KH, Heath RJ, Rock CO (2000) β-ketoacyl-acyl carrier protein synthase III (FabH) is
a determining factor inbranched-chain fatty acid biosynthesis. J Bacteriol 182(2):365–370.
30. Peralta-Yahya PP, Zhang F, del Cardayre SB, Keasling JD (2012) Microbial engineering
for the production of advanced biofuels. Nature 488(7411):320–328.
31. Akhtar MK, Turner NJ, Jones PR (2013) Carboxylic acid reductase is a versatile enzyme
for the conversion of fatty acids into fuels and chemical commodities. Proc Natl Acad
Sci USA 110(1):87–92.
32. Koma D, Yamanaka H, Moriyoshi K, Ohmoto T, Sakai K (2012) Production of aromatic
compounds by metabolically engineered Escherichia coli. Appl Environ Microbiol 78:14.
33. Zheng Y-N, et al. (2012) Optimization of fatty alcohol biosynthesis pathway for se-
lectively enhanced production of C12/14 and C16/18 fatty alcohols in engineered
Escherichia coli. Microb Cell Fact 11:11.
34. Westfall PJ, et al. (2012) Production of amorphadiene in yeast, and its conversion to
dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl
Acad Sci USA 109(3):E111–E118.
35. Ro DK, et al. (2006) Production of the antimalarial drug precursor artemisinic acid in
engineered yeast. Nature 440(7086):940–943.
36. Wargacki AJ, et al. (2012) An engineered microbial platform for direct biofuel pro-
duction from brown macroalgae. Science 335(6066):308–313.
37. Bokinsky G, et al. (2011) Synthesis of three advanced biofuels from ionic liquid-pre-
treated switchgrass using engineered Escherichia coli. Proc Natl Acad Sci USA 108(50):
19949–19954.
38. Handke P, Lynch SA, Gill RT (2011) Application and engineering of fatty acid bio-
synthesis in Escherichia coli for advanced fuels and chemicals.Metab Eng 13(1):28–37.
39. Dellomonaco C, Rivera C, Campbell P, Gonzalez R (2010) Engineered respiro-fer-
mentative metabolism for the production of biofuels and biochemicals from fatty
acid-rich feedstocks. Appl Environ Microbiol 76(15):5067–5078.
40. Zhang FF, Carothers JM, Keasling JD (2012) Design of a dynamic sensor-regulator system for
production of chemicals and fuels derived from fatty acids. Nat Biotechnol 30(4):354–359.
41. Dellomonaco C, Clomburg JM, Miller EN, Gonzalez R (2011) Engineered reversal of the
β-oxidation cycle for the synthesis of fuels and chemicals. Nature 476(7360):355–359.
42. Delebecque CJ, Lindner AB, Silver PA, Aldaye FA (2011) Organization of intracellular
reactions with rationally designed RNA assemblies. Science 333(6041):470–474.
43. Dueber JE, et al. (2009) Synthetic protein scaffolds provide modular control over
metabolic ﬂux. Nat Biotechnol 27(8):753–759.
44. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and
puriﬁcation of total lipides from animal tissues. J Biol Chem 226(1):497–509.
45. Berdyshev EV (2011) Mass spectrometry of fatty aldehydes. Biochim Biophys Acta
1811(11):680–693.
6 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1215966110 Howard et al.
Supporting Information
Howard et al. 10.1073/pnas.1215966110
A
MCS1 MCS2 
NpAD luxC luxE luxD 
HindIII NotI 
CEDDEC 
5-gene BCKD/bFabH2 operon 
bkdB bkdAA bkdAB acoL fabHB 
C
B
Thioesterase 
fatB1
Fig. S1. Genetic constructs used in this study. (A) Graphical representation of the luxC, luxE, luxD, and the aldehyde decarbonylase gene (CEDDEC) construct
used to introduce the alkane biosynthetic pathway (red in Fig. 1) into Escherichia coli. The amino acid sequences for LuxC, LuxE, and LuxD (accession
AAD05355.1, AAD05359.1, and P19197.1, respectively) were reverse-translated and codon-optimized for expression in E. coli using DNA2.0 GeneGPS Tech-
nology and synthesized as a single operon by DNA2.0 into the pACYCDuet-1 expression vector (Novagen) multiple cloning site (MCS) 1. The restriction enzyme
sites HindIII and NotI were used to remove the luxD gene as indicated in the results and discussion. The decarbonylase gene was cloned from genomic DNA
extracted from Nostoc punctiforme using the FastDNA SPIN Kit (MP Biomedicals) following the manufacturer’s instructions and puriﬁed further by phenol-
chloroform extraction and precipitation using ethanol and sodium acetate. The gene encoding aldehyde decarbonylase (NpAD) was ampliﬁed using Phusion
high-ﬁdelity DNA polymerase using cyanobacterial genomic DNA as template. Primers used were 5′ CATATGCAGCAGCTTACAGACCAAT 3′ and 5′ CTCGAGT-
TAAGCACCTATGAGTCCGTAGG 3′ allowing direct cloning into MCS2 of either pACYCDuet-1 or pCDFDuet-1 using the NdeI and XhoI sites (underlined). NpAD
sequence was conﬁrmed by DNA sequencing (Geneservice) of puriﬁed plasmids. The lux operon sequence and NpAD sequence (collectively CEDDEC) were
subsequently subcloned into pCDFDuet-1 MCS1 and MCS2 using NcoI and NotI (CED) and NdeI and XhoI (NpAD) sequences, respectively, for coexpression with
thioesterase and branched-chain modules. (B) The thioesterase amino acid sequence Q39473.1 minus the chloroplast transit peptide sequence (blue in Fig. 1)
was reverse-translated and codon-optimized for expression in E. coli using DNA2.0 GeneGPS Technology, synthesized by DNA2.0, and cloned into the MCS1 of
pETDuet-1 using the NcoI and BamHI restriction enzyme sites. (C) Graphical representation of the ﬁve-gene branched-chain α-keto acid dehydrogenase (BCKD)/
bFabH2 operon used to generate branched fatty acids (green in Fig. 1 and Fig. S2) in E. coli. All genes were reverse-translated and codon-optimized for E. coli
from the Bacillus subtilis amino acid sequences. The amino acid sequences for BCKD components (NP_390285.1, NP_390284.1, NP_390283.1, and
ZP_03600867.1) and for β-ketoacyl-ACP synthase III (KASIII) FabH2 (NP_388898.1) were reverse-translated and codon-optimized in silico using DNA2.0 GeneGPS
Technology, synthesized by DNA2.0, and cloned into pETDuet-1 MCS1 using NcoI and NotI sites.
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Fig. S3. Mass spectral data for methyl pentadecane and tridecane identiﬁed in Figs. 4 and 5, respectively. (A) The mass spectral data for methyl pentadecane
(black) and for the 15:0* (Fig. 4B) peak (red). The structure of methyl pentadecane is inset. (B) The mass spectral data for tridecane (black) and for the 13:0 peak
(red). The structure of tridecane is inset.
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Fig. S4. Creation of a tetradecanoic acid substrate pool in E. coli. E. coli cells harboring the fatB1 thioesterase gene without transit peptide sequence from C.
camphor in MCS1 of the expression vector pETDuet-1 were grown and induced as described in Experimental Procedures. (A) GC-MS total ion chromatograms
(TIC) of FA extracted from control cells. (B) GC-MS TIC of FA extracted from cells expressing fatB1.
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Fig. S5. Detection and optimization of alkane biosynthesis in BL21* (DE3) cells using the pETDuet expression system. (A) Heptadecane and heptadecene
standards were linear down to 5 μg·mL−1. (B) Standards were recovered at 100% and 70%, respectively, from samples spiked with 12.5 μg heptadecane or
heptadecene. (C) Cells carrying either the cyanobacterial pathway [black symbols, reported previously (1)], or the artiﬁcial CEDDEC pathway described here
(white symbols) were grown in 1.5% (triangle), 3% (diamond), or 6% glucose (square), and protein expression was induced at OD 0.6 (Left) or OD 1.2 (Right)
with 20 μM isopropylthiogalactoside (IPTG). (D) Alkanes recovered from cells expressing the CEDDEC pathway from plasmids pACYC (low copy number), pCDF
(medium copy number), or pRSF (high copy number).
1. Schirmer A, Rude MA, Li XZ, Popova E, del Cardayre SB (2010) Microbial biosynthesis of alkanes. Science 329(5991):559–562.
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Fig. S6. Fatty aldehyde pools in E. coli cells. Liquid chromatography mass spectrometry (LCMS) TIC of fatty aldehydes (Top to Bottom) from BL21* (DE3) cells
with no plasmid, cells expressing the cyanobacterial pathway, cells expressing the artiﬁcial CEDDEC pathway, and cells expressing the CEDDEC pathway in the
presence of exogenous tetradecanoic acid at 100 μg·mL−1 supplementation. Cells grown in the presence of tetradecanoic acid but without induction did not
reveal the presence of fatty aldehydes.
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